Scientists probe gut leaks in IBS patients
NCT ID NCT00742118
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at colon tissue samples from 200 people with irritable bowel syndrome (IBS) to understand why their gut barrier may be leaky. Researchers tested whether substances released by mast cells (a type of immune cell) can damage the gut lining and nerves. The goal is to find new targets for IBS treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could point toward new treatments for IBS by targeting gut barrier problems.
- What could go wrong
- This is an observational study, not a treatment trial. Results may not lead directly to therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IRRITABLE BOWEL SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of gastroenterology, Hopital Archet 2
Nice, 06002, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could simple exercises calm gut inflammation and boost quality of life in IBS?
- Gut bacteria during infection may flag IBS risk
- Wheat sensitivity linked to fatty liver? a new study investigates
- Could a daily probiotic capsule tame irritable bowel syndrome?
- Can a simple diet switch calm IBS? a trial puts two popular eating plans to the test.
- Could a Dual-Action supplement tame irritable bowel syndrome?